Vimarsana
Biggest News Aggregation in the World

Page 15 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Paratek Pharmaceuticals, Inc. (PRTK) Q3 2022 Earnings Call Transcript - Vimarsana News

Paratek Pharmaceuticals, Inc. (PRTK) Q3 2022 Earnings Call Transcript

Paratek Pharmaceuticals, Inc. (NASDAQ:NASDAQ:PRTK) Q3 2022 Earnings Conference Call November 03, 2022, 16:30 ET Company Participants Sarah Higgins - VP, Finance, Controller & Principal...

Soligenix Invited to Submit BARDA Contract Proposal for Development of Thermostabilized Subunit Vaccines for Sudan Ebola and Marburg Viruses - Vimarsana News

Soligenix Invited to Submit BARDA Contract Proposal for Development of Thermostabilized Subunit Vaccines for Sudan Ebola and Marburg Viruses

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Soligenix Announces Formation of Psoriasis Medical Advisory Board - Vimarsana News

Soligenix Announces Formation of Psoriasis Medical Advisory Board

Phase 2a clinical study in mild-to-moderate psoriasis initiating in December 2022PRINCETON, N.J., Oct. 25, 2022 /PRNewswire/ -- Soligenix, Inc. (N...

HHS Makes $290 Million Purchase - San Fernando Valley Business Journal - Vimarsana News

HHS Makes $290 Million Purchase - San Fernando Valley Business Journal

The United States Department of Health and Human Services (HHS) announced early this month that it was purchasing a $290 million supply of Nplate, a drug from Thousand Oaks-based Amgen.

Source: sfvbj.com
Soligenix Announces Adjournment of Annual Meeting and Information for Reconvened Meeting - Vimarsana News

Soligenix Announces Adjournment of Annual Meeting and Information for Reconvened Meeting

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...